Usefulness of contrast-enhanced ultrasonography with Sonazoid for diagnosis and liver function assessment for Non-alcoholic steatohepatitis (NASH).

Usefulness of contrast-enhanced ultrasonography with Sonazoid for diagnosis and liver function assessment for Non-alcoholic steatohepatitis (NASH). - Diagnosis and liver function assessment for Non-alcoholic steatohepatitis (NASH).

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000014400

Enrollment

Registered

2014-07-01

Start date

2014-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

non-alcoholic fatty liver disease

Interventions

Estimate the value phagocytosis function of Kupffer cells.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Outpatient with NAFLD not accordant to inappropriate condition. The person judged appropriate by principal doctor and investigator. Normal subjects not accordant to inappropriate condition. Criterion of selection is the person with BMI more than 18.5 and less than 25.0 (criterion of Japan Society of the Study of Obesity) and without liver disease.

Exclusion criteria

Exclusion criteria: Under 18 years old. History of allergy to ingredients of this agent. Allergy to eggs or dairy products. Arteriovenous shunt at heart or lung. Heart disease. Lung disease. Disagree with participation in this investgation.

Design outcomes

Primary

Measure	Time frame
NASH is efficiently picked up from the patient population of a non-alcoholic fatty liver.	—

Countries

Japan

Contacts

Public ContactTakashi Shida

Faculty of Medicine, University of Tsukuba Medical Science

shida.mim03@gmail.com029-853-3291

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026